Guo, W., Wang, M., Shin, J., Li, F., Obrien, E., Glover, L., Bortfeld, K., Aymes, S., Porter, M., Grory, B. M., Lusk, J. (2025). Abstract 4367419: Glucagon-Like Peptide-1 Receptor Agonist Use Is Associated With Lower Risk Of Cardiovascular Event Recurrence Compared With Use Of Bupropion-Naltrexone or Phentermine-Topiramate: A Nationwide Target Trial Emulation Study. Circulation. https://doi.org/10.1161/circ.152.suppl_3.4367419